Ott, C., Jung, S., Korn, M., Kannenkeril, D., Bosch, A., Kolwelter, J., . . . Schmieder, R. E. (2022). Renal hemodynamic effects differ between antidiabetic combination strategies: Randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargine. Friedrich-Alexander-Universität Erlangen-Nürnberg.
Chicago-Zitierstil (17. Ausg.)Ott, Christian, et al. Renal Hemodynamic Effects Differ Between Antidiabetic Combination Strategies: Randomized Controlled Clinical Trial Comparing Empagliflozin/linagliptin with Metformin/insulin Glargine. Erlangen ; Nürnberg: Friedrich-Alexander-Universität Erlangen-Nürnberg, 2022.
MLA-Zitierstil (9. Ausg.)Ott, Christian, et al. Renal Hemodynamic Effects Differ Between Antidiabetic Combination Strategies: Randomized Controlled Clinical Trial Comparing Empagliflozin/linagliptin with Metformin/insulin Glargine. Friedrich-Alexander-Universität Erlangen-Nürnberg, 2022.